New gene selection method for classification of cancer subtypes considering within-class variation  by Cho, Ji-Hoon et al.
New gene selection method for classi¢cation of cancer subtypes
considering within-class variation
Ji-Hoon Choa, Dongkwon Leea, Jin Hyun Parkb, In-Beum Leea;
aDepartment of Chemical Engineering, Pohang University of Science and Technology, San 31 Hyoja-Dong, Pohang 790-784, South Korea
bPpI Consulting Co., Ltd., San 31 Hyoja-Dong, Pohang 790-784, South Korea
Received 5 May 2003; accepted 13 July 2003
First published online 11 August 2003
Edited by Julio Celis
Abstract In this work we propose a new method for ¢nding
gene subsets of microarray data that e¡ectively discriminates
subtypes of disease. We developed a new criterion for measuring
the relevance of individual genes by using mean and standard
deviation of distances from each sample to the class centroid in
order to treat the well-known problem of gene selection, large
within-class variation. Also this approach has the advantage
that it is applicable not only to binary classi¢cation but also
to multiple classi¢cation problems. We demonstrated the per-
formance of the method by applying it to the publicly available
microarray datasets, leukemia (two classes) and small round
blue cell tumors (four classes). The proposed method provides
a very small number of genes compared with the previous meth-
ods without loss of discriminating power and thus it can e¡ec-
tively facilitate further biological and clinical researches.
" 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Gene selection (the choice of discriminatory genes) is one of
the most challenging issues in the ¢eld of microarray data
analysis. Gene expression data generally contains a large num-
ber of genes (variables) compared to the number of samples,
hence conventional data mining techniques cannot be directly
applied to the data [1,2,11] due to the singularity problem, the
curse of dimensionality and so on. For this reason, the anal-
ysis of gene expression data needs performing a dimension
reduction technique, gene selection which subtracts the genes
most highly correlated to the pattern of each type of disease in
order to avoid such problems. Statistical approaches including
parametric and non-parametric tests, for example t-test and
Wilcoxon rank sum test, have been widely used for ¢nding
di¡erentially expressed genes since they are easy to understand
and implement. However, they have a potential limitation to
extend in the case of more than two classes and require time-
consuming adjustment to solve the problem of multiple testing
[3]. For three or more groups, the Kruskal^Wallis test can be
used. However, it may produce biased results because of the
dependence on the number of samples, when it is applied to
microarray data whose sample sizes are usually unbalanced.
In addition to the statistical methods, extensive researches
have focused on gene selection. Golub et al. [4] used signal-to-
noise ratio as a criterion for measuring the correlation be-
tween a gene and a cancer subtype. Hastie et al. [5] developed
the so-called gene shaving method with principal component
analysis. Recently, Tibshirani et al. [6] suggested the nearest
shrunken centroid method combined with classi¢cation and
Lee et al. [15] selected the informative gene subset using Baye-
sian learning. Also, Guyon et al. [7] adopted the support
vector machine for recursive feature extraction. These meth-
ods can be divided into two categories: individual gene rank-
ing approaches and gene subset ranking approaches [8].
Here, in a supervised manner, we propose a novel gene
selection method which belongs to the individual gene ranking
approaches, with emphasis on small within-class variation
(homogeneity in a certain class) as well as di¡erential expres-
sion between groups. Our proposed method consists of two
steps, one is a gene ranking and selection step and the other is
a validation step. Utilizing sample distances from the centroid
of each class, we developed a new metric which re£ects the
relevance of a gene and ranked genes according to the metric.
For validating the classi¢cation ability of selected genes, we
used the kernel Fisher’s discriminant analysis (KFDA) which
is a remarkable technique for analyzing gene expression data
since it is irrespective of the number of variables (genes) and it
generally provides satisfactory results [9]. The main advantage
of our method is that it guarantees small within-class varia-
tion which has been indicated as a drawback of this kind of
method (so-called individual gene ranking approach) [8] and it
is simply extended when there are more than two classes. A
subset which shows a minimum test error rate is chosen as an
optimal candidate set for classi¢cation of cancer subtypes. To
evaluate the performance of our proposed method, we applied
it to publicly available microarray datasets, acute leukemia [4]
and small round blue cell tumors (SRBCT) [10].
2. Materials and methods
2.1. Biological data
The leukemia dataset has 7129 probes and 72 train samples and test
ones and the SRBCT dataset has 2308 genes (including expressed
sequence tags) that were preliminarily chosen by Khan et al. [10]
and a total of 83 samples (we removed ¢ve non-SRBCT samples).
The former dataset has two classes, acute lymphoblast leukemia
(ALL) and acute myeloid leukemia (AML), and the latter is classi¢ed
into four classes, Burkitt’s lymphoma (BL), Ewing’s sarcoma (EWS),
rhabdomyosarcoma (RMS), and neuroblastoma (NB). Both datasets
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are publicly available at http://www-genome.wi.mit.edu/cancer and
http://research.nhgri.nih.gov/microarray/Supplement/index.html.
2.2. Mathematical formulation of a new metric
The basic idea of this method is to identify genes which have short
distances from each class centroid and have simultaneously small
variation within the class. Assume that we have two-dimensional
data which has two classes as shown in Fig. 1. In the ¢gure, one
can intuitively recognize that x1 is relevant for discriminating two
classes since samples of x1 are not distant from the each class centroid
and show little variation within each class. In brief, the distance vector
of relevant variable x1 is composed of small distance values and thus
has small variance as well as small mean value.
Suppose that we have pUn data matrix, X and xij be the expression
for ith gene and jth sample (i=1, 2, T, p and j=1, 2, T, n). The data
have total K classes and nk samples in class k. Let Ck be the index of
the samples in the kth class. The expression value of each gene is
assumed to be auto-scaled.
The ith element of the centroid for class k is obtained as follows.
xik ¼ 1=nk
X
jnCk
xij ð1Þ
It represents the mean expression value in class k for gene i. We de¢ne
a distance matrix, Z, of which each element zij is calculated as follows.
zij ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðxij3xikÞ2
p
; where jnCk ð2Þ
We name zi (1Un row vector) the within-class distance vector of
gene i since zi consists of n1 distances from the centroid of class 1, n2
distances from the centroid of class 2, T, and nK distances from the
centroid of class K, i.e. total n distances from each class centroid. The
schematic diagram of the mathematical procedure is con¢gured in
Fig. 2 and conceptual illustration is shown in Fig. 3.
If gene i is suitable for classi¢cation (di¡erentially expressed across
cancer subtypes and homogeneously dispersed within each class), zi,
the corresponding within-class distance vector, has a small standard
deviation with a small mean value. Note that the sample mean and
standard deviations depend upon the number of samples, which may
distort the statistics especially for the case of multiple classes. Con-
sider that we have three distance vectors, zi, zj and zk as follows.
The sample mean and standard deviation of the vectors are di¡erent.
However, we want to make the statistic of three vectors be equal and
thus eliminate the e¡ect of the number of samples since they have the
same property, i.e. a distance value of 1 for a certain class and 0 for
other classes. Weighted mean and standard deviation (variance) can
achieve our aim and they are formulized as follows.
For gene i,
meanwðziÞ ¼
Xn
j¼1
wj
W
zij ð3Þ
stdwðziÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
j¼1
ðzij3meanwðziÞÞ2
ðn31=nÞ
Xn
j¼1
wj
vuuuuuuut
ð4Þ
where W ¼Pnj¼1wj ; wj ¼
1
nk
ðjnCkÞ
Thus, we develop a new metric which re£ects the relevance of gene i
as follows.
ri ¼ meanwðziÞWstdwðziÞ ð5Þ
The small value of ri suggests that samples of the ith gene are
dispersed near the centroid of each class (mean value of zi) and are
assembled (standard deviation of zi) simultaneously. And hence we
can conclude that the ith gene is subtype-speci¢c and has small within-
class variation. It is necessary to consider the mean and variation
(standard deviation) together, since it is possible for two distance
vectors, zi and zj , to have the same standard deviation although
they have di¡erent mean values.
However, there is a fatal weak point. If there is a gene which shows
no di¡erential expression across classes and nearly uniform expres-
sion, it will be chosen as a relevant gene with regard to the ri value.
To prevent such a situation, we included the di¡erence of the centroid
of each class and modi¢ed ri as follows.
Ri ¼ meanwðziÞWstdwðziÞstdðxiÞ ð6Þ
where x ¼ ½xi1; xi2; T; xiK  denotes the 1UK centroid vector of gene i
and std(W) means standard deviation calculation.
2.3. Classi¢cation strategy
For classi¢cation of samples, we chose to use KFDA [9]. While the
conventional Fisher’s discriminant analysis (FDA) does not work
when there is a larger number of variables than samples due to the
singularity problem [1,2,11], KFDA is very e¡ective for gene expres-
sion data with high dimensionality since the kernel methods use dot
products and do not need to perform high dimensional matrix com-
putation [9,12]. Using the kernel trick, we can obtain n (the number of
samples which is usually less than 100)-dimensional scatter matrices
which are invertible so that they can produce projection weight vector
(or matrix). One can ¢nd the detailed algorithm of KFDA in the
literature [9]. For each selected gene subset, we obtained KFDA
scores (generally one less than K, the number of classes) in the
same way as conventional FDA and classi¢ed them by calculating
posterior probabilities.
The classi¢cation is achieved by the following procedure. With the
projection weight vector, we can obtain the discriminant function
(score), yj (K31U1 column vector) of input xj (j=1, 2, T, n). Then,
the chi-square distance of the jth sample from the centroid of each
class is computed by
M 2j;k ¼ ðyj3ykÞTD31k ðyj3ykÞ ð7Þ
where Dk is the covariance matrix of y for class k and
Fig. 1. Plot of simulated dataset. The relevant variable, x1, shows
two distributions that are apart from each other and have small
variation (standard deviation).
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yk ¼ 1=nk
P
jnCkyj denotes a class centroid of discriminant score. The
posterior probability is calculated as follows:
PðkMxjÞ ¼
PkMDkM31=2expð3M 2j;k=2ÞX
k0
Pk0MDk0M31=2expð3M 2j;k0=2Þ
ð8Þ
where Pk is the prior probability for class k. A sample is assigned into
the class for which P(kMxj) is highest. Note that if the number of
samples for a certain class is less than the number of classes, one
cannot calculate the Fisher’s discriminant function due to rank de¢-
ciency of matrix, D.
3. Results
We analyzed the two datasets which represent binary clas-
si¢cation and multiple classi¢cation problems, respectively.
The procedure is as follows. Removing the proportion, K
(in this paper, K=20%) of the genes having largest value of
Ri, we monitored the classi¢cation error rate using KFDA
and posterior probabilities. We used ¢ve-fold cross-validation,
i.e. partitioned the set of samples into ¢ve approximately
equal-sized parts. We trained the classi¢er with four parts
and then predicted the class of the remaining part for evalu-
ating test error rate. The distribution of class labels should be
roughly balanced so that each sample is predicted for one time
and only one. This procedure should be repeated ¢ve times
and the mean error on all ¢ve times produces the mean cross-
validation error. Also, we repeated such cross-validation 20
times and took an overall mean cross-validation error rate,
considering the arbitrariness of partitioning (therefore a total
Fig. 2. Schematic diagram of the mathematical formulation proce-
dure.
Fig. 3. Conceptual illustration of within-class distance vector, zi .
The bar indicates the gene expression value of each sample and the
horizontal line represents the value of each class centroid. Both
genes have a similar mean di¡erence between two classes, but gene
1 is more suitable and robust for classi¢cation since it has small
within-class variation. Consequently, the within-class distance vector
of gene 1 shows a small mean and standard deviation.
Fig. 4. Classi¢cation error rate of two datasets: (a) leukemia and
(b) SRBCT. Train and test error are shown as a function of the
number of genes always used during total cross-validation. The
dashed line indicates the minimum test error point.
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of 100 validations were performed). As a result, we could
extract a discriminatory gene subset which showed the mini-
mum cross-validation error rate.
3.1. Classi¢cation and gene subset selection
Fig. 4 shows the results of the cross-validation for the two
datasets. As expected, the test error tends to decrease with
eliminating irrelevant genes. During the cross-validation, the
leukemia dataset showed the minimum test error (overall
mean cross-validation error, 4.06%) when 6 genes were always
used during the total of 100 validation procedures. For the
SRBCT data, 21 genes which also always participated in the
whole 100 validations gave the minimum overall mean error
(0.96%). We considered the above gene subset (6 genes for
leukemia and 21 genes for SRBCT) as optimal gene sets for
classi¢cation of subtypes. For evaluation of optimality, se-
lected gene subsets passed through leave-one-out cross-valida-
tion (LOOCV) using conventional FDA and KFDA. Table 1
represents the LOOCV classi¢cation results of our selected
gene subset and previously published ones for comparison.
As one can see, our method markedly reduced the number
of genes without loss of separability.
For the leukemia data, recently Lee et al. [15] successfully
found the relevance of genes using the Bayesian learning
method and made a good classi¢cation result, but their gene
selection criterion was somewhat arbitrary. As for the SRBCT
data, Tibshirani et al. [6] developed a new technique for gene
selection and found 43 genes as an optimal set, however, in
spite of reducing many genes compared with Khan et al. [10],
we concluded that their selection was still relevant according
to the comparison results. On the contrary, our method se-
lected the minimal number of genes with explicit selection
criteria based on cross-validated classi¢cation performance.
Note that we provided most plausible classi¢cation results
since we did not make any assumption (e.g. diagonal with-
in-covariance matrix as [6]) in the comparison study. Fig. 5
e¡ectively illustrates the gene selection performance of our
method. From the ¢gure, we can see that selected genes
have a signi¢cant mean di¡erence between groups (speci¢c
subtype and others) and also have small variation within
each group, and thus we can consider that they are de¢nitely
discriminatory.
3.2. Biological analysis of identi¢ed genes
Many studies have been accomplished with the leukemia
data [2,4,13^15], and most genes we found were part of pre-
viously chosen ones. We also found 21 genes most responsible
for SRBCT subtype classi¢cation. Previous studies already
addressed that they were responsible for subtype classi¢cation
of SRBCT and suggested plausible conclusions about the bio-
logical function of the genes [6,10]. However, we identi¢ed
some genes not identi¢ed in other works for SRBCT. We
found the Wiskott^Aldrich syndrome (WAS) gene, overex-
pressed in Burkitt’s lymphoma, known to be associated with
Bruton’s tyrosine kinase which plays an important role in
normal B-cell lymphocyte development [16]. Some publica-
tions have reported that the WAS gene is included in lym-
phoid cell signaling and its expression levels play a substantial
role in determining immune outcome [17,18]. This result
Table 1
LOOCV classi¢cation results of our proposed gene subset and previ-
ously selected ones: (a) leukemia data and (b) SRBCT data
Conventional
FDA
KFDA Number
of genes
a: Leukemia data
Golub et al. [4] 9 4 50
Lee et al. [15] 5 3 5
Proposed 3 2 6
b: SRBCT data
Tibshirani et al. [6] 2 2 43
Proposed 0 0 21
Numerical values indicate the number of misclassi¢cations.
Fig. 5. Gene expression maps of the selected genes for (a) leukemia and (b) SRBCT. Within each of the cancer types, the genes are ordered by
hierarchical clustering (average linkage) for clear illustration. We used CLUSTER and TREEVIEW software which are publicly available at
http://rana.lbl.gov.
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might re£ect the fact that one with immunode¢ciency (e.g.
WAS) has a high possibility of lymphoid malignancy (non-
Hodgkin lymphoma) [19,20].
4. Discussion
Gene selection is a crucial step for analyzing microarray
data since there are a large number of genes (irrelevance),
which makes it di⁄cult to handle such data. In this paper,
we proposed a novel gene selection criterion combined with
KFDA. Intuitively, the goal of the proposed method is to ¢nd
the minimal set of genes that are closely located around the
class centroid and thus can e¡ectively discriminate cancer
patterns. We adopted a so-called individual gene ranking ap-
proach to sort several thousands genes and the KFDA meth-
od to evaluate the classi¢cation power of a selected subset of
genes. In fact, it has been reported that the individual ranking
method has the disadvantage that genes found by the method
might not have small within-class variation [8]. This problem
was solved by considering mean and standard deviation of
sample distances from the class centroid. In addition, by con-
sidering weighted metrics, we removed the dependence on the
sample size of each class. The proposed method gave a sat-
isfactory classi¢cation performance with informative genes
which are speci¢c to a certain type of cancer. Moreover, it
considerably reduced the complexity of the data without loss
of class prediction performance even in the multiple classi¢-
cation problems. Although it is hard to assess that only a
selected subset of genes is optimal for classifying subtypes,
such genes may be strong candidates which represent a certain
type of cancer. With the informative subset, one may improve
the discriminatory power as much as possible by combining
with other supervised pattern recognition techniques. Lastly,
this kind of work would be used to ¢nd responsive drug
targets. If proper gene selection is accompanied by biological
and clinical research, our work may speed up and facilitate
experimental work and thus be the cornerstone of therapeutic
target discovery.
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